Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-02-03 @ 3:29 AM
Study NCT ID:
NCT03247218
Status:
UNKNOWN
Last Update Posted:
2019-11-01
First Post:
2017-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD
Sponsor:
HaEmek Medical Center, Israel
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sickle Cell Disease | View |
Keywords: